<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33508151</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-6860</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title><ISOAbbreviation>FASEB J</ISOAbbreviation></Journal><ArticleTitle>Altered expression of clock and clock-controlled genes in a hSOD1-linked amyotrophic lateral sclerosis mouse model.</ArticleTitle><Pagination><StartPage>e21343</StartPage><MedlinePgn>e21343</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1096/fj.202000386RR</ELocationID><Abstract><AbstractText>Most physiological processes in mammals are subjected to daily oscillations that are governed by a circadian system. The circadian rhythm orchestrates metabolic pathways in a time-dependent manner and loss of circadian timekeeping has been associated with cellular and system-wide alterations in metabolism, redox homeostasis, and inflammation. Here, we investigated the expression of clock and clock-controlled genes in multiple tissues (suprachiasmatic nucleus, spinal cord, gastrocnemius muscle, and liver) from mutant hSOD1-linked amyotrophic lateral sclerosis (ALS) mouse models. We identified tissue-specific changes in the relative expression, as well as altered daily expression patterns, of clock genes, sirtuins (Sirt1, Sirt3, and Sirt6), metabolic enzymes (Pfkfb3, Cpt1, and Nampt), and redox regulators (Nrf2, G6pd, and Pgd). In addition, astrocytes transdifferentiated from induced pluripotent stem cells from SOD1-linked and FUS RNA binding protein-linked ALS patients also displayed altered expression of clock genes. Overall, our results raise the possibility of disrupted cross-talk between the suprachiasmatic nucleus and peripheral tissues in hSOD1<sup>G93A</sup> mice, preventing proper peripheral clock regulation and synchronization. Since these changes were observed in symptomatic mice, it remains unclear whether this dysregulation directly drives or it is a consequence of the degenerative process. However, because metabolism and redox homeostasis are intimately entangled with circadian rhythms, our data suggest that altered expression of clock genes may contribute to metabolic and redox impairment in ALS. Since circadian dyssynchrony can be rescued, these results provide the groundwork for potential disease-modifying interventions.</AbstractText><CopyrightInformation>&#xa9; 2021 Federation of American Societies for Experimental Biology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Killoy</LastName><ForeName>Kelby M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Biomedical Sciences Training Program, Medical University of South Carolina, Charleston, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pehar</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harlan</LastName><ForeName>Benjamin A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Biomedical Sciences Training Program, Medical University of South Carolina, Charleston, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vargas</LastName><ForeName>Marcelo R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS089640</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS102599</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>FASEB J</MedlineTA><NlmUniqueID>8804484</NlmUniqueID><ISSNLinking>0892-6638</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495636">Nfe2l2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.1.1.43</RegistryNumber><NameOfSubstance UI="D010734">Phosphogluconate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.1.1.49</RegistryNumber><NameOfSubstance UI="D005954">Glucosephosphate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.21</RegistryNumber><NameOfSubstance UI="D002334">Carnitine O-Palmitoyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.48</RegistryNumber><NameOfSubstance UI="D056926">CLOCK Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.2.12</RegistryNumber><NameOfSubstance UI="D054409">Nicotinamide Phosphoribosyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.2.12</RegistryNumber><NameOfSubstance UI="C495867">nicotinamide phosphoribosyltransferase, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.105</RegistryNumber><NameOfSubstance UI="C000595376">PFKFB3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.105</RegistryNumber><NameOfSubstance UI="D025481">Phosphofructokinase-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.1.-</RegistryNumber><NameOfSubstance UI="D037761">Sirtuins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056926" MajorTopicYN="N">CLOCK Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002334" MajorTopicYN="N">Carnitine O-Palmitoyltransferase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005954" MajorTopicYN="N">Glucosephosphate Dehydrogenase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051267" MajorTopicYN="N">NF-E2-Related Factor 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054409" MajorTopicYN="N">Nicotinamide Phosphoribosyltransferase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025481" MajorTopicYN="N">Phosphofructokinase-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010734" MajorTopicYN="N">Phosphogluconate Dehydrogenase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037761" MajorTopicYN="N">Sirtuins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Nampt</Keyword><Keyword MajorTopicYN="N">Sirt6</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">circadian</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword></KeywordList><CoiStatement><b>Conflict of interest:</b> The authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>28</Day><Hour>17</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33508151</ArticleId><ArticleId IdType="mid">NIHMS1678901</ArticleId><ArticleId IdType="pmc">PMC7963346</ArticleId><ArticleId IdType="doi">10.1096/fj.202000386RR</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Reppert SM, and Weaver DR (2001) Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63, 647&#x2013;676</Citation><ArticleIdList><ArticleId IdType="pubmed">11181971</ArticleId></ArticleIdList></Reference><Reference><Citation>Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, and Schibler U (2002) The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 110, 251&#x2013;260</Citation><ArticleIdList><ArticleId IdType="pubmed">12150932</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda HR, Chen W, Adachi A, Wakamatsu H, Hayashi S, Takasugi T, Nagano M, Nakahama K, Suzuki Y, Sugano S, Iino M, Shigeyoshi Y, and Hashimoto S (2002) A transcription factor response element for gene expression during circadian night. Nature 418, 534&#x2013;539</Citation><ArticleIdList><ArticleId IdType="pubmed">12152080</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato TK, Panda S, Miraglia LJ, Reyes TM, Rudic RD, McNamara P, Naik KA, FitzGerald GA, Kay SA, and Hogenesch JB (2004) A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron 43, 527&#x2013;537</Citation><ArticleIdList><ArticleId IdType="pubmed">15312651</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chio A, and Traynor BJ (2014) State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17, 17&#x2013;23</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O&#x2019;Regan JP, Deng HX, and et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59&#x2013;62</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, and et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772&#x2013;1775</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, and Cleveland DW (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327&#x2013;338</Citation><ArticleIdList><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat PF, Ludolph AC, and Loeffler JP (2011) Energy metabolism in amyotrophic lateral sclerosis. Lancet neurology 10, 75&#x2013;82</Citation><ArticleIdList><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, and Loeffler JP (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proceedings of the National Academy of Sciences of the United States of America 101, 11159&#x2013;11164</Citation><ArticleIdList><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Funalot B, Desport JC, Sturtz F, Camu W, and Couratier P (2009) High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 10, 113&#x2013;117</Citation><ArticleIdList><ArticleId IdType="pubmed">18792852</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, and Couratier P (2009) Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 256, 1236&#x2013;1242</Citation><ArticleIdList><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim MA, Bence KK, Sandesara I, Andreux P, Auwerx J, Ishibashi J, Seale P, and Kalb RG (2014) Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis. Human molecular genetics 23, 4995&#x2013;5008</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4140473</ArticleId><ArticleId IdType="pubmed">24833719</ArticleId></ArticleIdList></Reference><Reference><Citation>Patacchioli FR, Monnazzi P, Scontrini A, Tremante E, Caridi I, Brunetti E, Buttarelli FR, and Pontieri FE (2003) Adrenal dysregulation in amyotrophic lateral sclerosis. Journal of endocrinological investigation 26, RC23&#x2013;25</Citation><ArticleIdList><ArticleId IdType="pubmed">15055464</ArticleId></ArticleIdList></Reference><Reference><Citation>Monachelli GG, Meyer M, Rodriguez G, Garay L, Sica RE, De Nicola AF, and Gonzalez Deniselle MC (2011) Progesterone and cortisol levels in sporadic amyotrophic lateral sclerosis (sALS): correlation with prognostic factors. Hormone molecular biology and clinical investigation 6, 167&#x2013;173</Citation><ArticleIdList><ArticleId IdType="pubmed">25961252</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R, Volanti P, Vitale F, Meli F, Colletti T, Di Natale A, and La Bella V (2015) Plasma cortisol level in amyotrophic lateral sclerosis. Journal of the neurological sciences 358, 282&#x2013;286</Citation><ArticleIdList><ArticleId IdType="pubmed">26384616</ArticleId></ArticleIdList></Reference><Reference><Citation>Fidler JA, Treleaven CM, Frakes A, Tamsett TJ, McCrate M, Cheng SH, Shihabuddin LS, Kaspar BK, and Dodge JC (2011) Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 25, 4369&#x2013;4377</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3236626</ArticleId><ArticleId IdType="pubmed">21876068</ArticleId></ArticleIdList></Reference><Reference><Citation>Morselli LL, Bongioanni P, Genovesi M, Licitra R, Rossi B, Murri L, Rossi G, Martino E, and Gasperi M (2006) Growth hormone secretion is impaired in amyotrophic lateral sclerosis. Clinical endocrinology 65, 385&#x2013;388</Citation><ArticleIdList><ArticleId IdType="pubmed">16918961</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, Ngo ST, Lee JD, Leong JW, Buckley AJ, Veldhuis JD, McCombe PA, Chen C, and Bellingham MC (2012) Impairments to the GH-IGF-I axis in hSOD1G93A mice give insight into possible mechanisms of GH dysregulation in patients with amyotrophic lateral sclerosis. Endocrinology 153, 3735&#x2013;3746</Citation><ArticleIdList><ArticleId IdType="pubmed">22621959</ArticleId></ArticleIdList></Reference><Reference><Citation>Bass J, and Takahashi JS (2010) Circadian integration of metabolism and energetics. Science 330, 1349&#x2013;1354</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756146</ArticleId><ArticleId IdType="pubmed">21127246</ArticleId></ArticleIdList></Reference><Reference><Citation>Tevy MF, Giebultowicz J, Pincus Z, Mazzoccoli G, and Vinciguerra M (2013) Aging signaling pathways and circadian clock-dependent metabolic derangements. Trends in endocrinology and metabolism: TEM 24, 229&#x2013;237</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3624052</ArticleId><ArticleId IdType="pubmed">23299029</ArticleId></ArticleIdList></Reference><Reference><Citation>Peek CB, Affinati AH, Ramsey KM, Kuo HY, Yu W, Sena LA, Ilkayeva O, Marcheva B, Kobayashi Y, Omura C, Levine DC, Bacsik DJ, Gius D, Newgard CB, Goetzman E, Chandel NS, Denu JM, Mrksich M, and Bass J (2013) Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science 342, 1243417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3963134</ArticleId><ArticleId IdType="pubmed">24051248</ArticleId></ArticleIdList></Reference><Reference><Citation>Schibler U, Gotic I, Saini C, Gos P, Curie T, Emmenegger Y, Sinturel F, Gosselin P, Gerber A, Fleury-Olela F, Rando G, Demarque M, and Franken P (2015) Clock-Talk: Interactions between Central and Peripheral Circadian Oscillators in Mammals. Cold Spring Harbor symposia on quantitative biology 80, 223&#x2013;232</Citation><ArticleIdList><ArticleId IdType="pubmed">26683231</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiga F, and Lightman SL (2015) Dynamics of adrenal glucocorticoid steroidogenesis in health and disease. Molecular and cellular endocrinology 408, 227&#x2013;234</Citation><ArticleIdList><ArticleId IdType="pubmed">25662280</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattis J, and Sehgal A (2016) Circadian Rhythms, Sleep, and Disorders of Aging. Trends Endocrinol Metab 27, 192&#x2013;203</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4808513</ArticleId><ArticleId IdType="pubmed">26947521</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlpine CS, and Swirski FK (2016) Circadian Influence on Metabolism and Inflammation in Atherosclerosis. Circulation research 119, 131&#x2013;141</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4922503</ArticleId><ArticleId IdType="pubmed">27340272</ArticleId></ArticleIdList></Reference><Reference><Citation>Videnovic A, Lazar AS, Barker RA, and Overeem S (2014) &#x2018;The clocks that time us&#x2019;--circadian rhythms in neurodegenerative disorders. Nature reviews. Neurology 10, 683&#x2013;693</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4344830</ArticleId><ArticleId IdType="pubmed">25385339</ArticleId></ArticleIdList></Reference><Reference><Citation>Musiek ES, and Holtzman DM (2016) Mechanisms linking circadian clocks, sleep, and neurodegeneration. Science 354, 1004&#x2013;1008</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5219881</ArticleId><ArticleId IdType="pubmed">27885006</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Xu G, Gonzales V, Coonfield M, Fromholt D, Copeland NG, Jenkins NA, and Borchelt DR (2002) Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiology of disease 10, 128&#x2013;138</Citation><ArticleIdList><ArticleId IdType="pubmed">12127151</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlan BA, Pehar M, Killoy KM, and Vargas MR (2019) Enhanced SIRT6 activity abrogates the neurotoxic phenotype of astrocytes expressing ALS-linked mutant SOD1. FASEB J 33, 7084&#x2013;7091</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6529338</ArticleId><ArticleId IdType="pubmed">30841754</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G, Anafi RC, Hughes ME, Kornacker K, and Hogenesch JB (2016) MetaCycle: an integrated R package to evaluate periodicity in large scale data. Bioinformatics 32, 3351&#x2013;3353</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5079475</ArticleId><ArticleId IdType="pubmed">27378304</ArticleId></ArticleIdList></Reference><Reference><Citation>Refinetti R, Lissen GC, and Halberg F (2007) Procedures for numerical analysis of circadian rhythms. Biol Rhythm Res 38, 275&#x2013;325</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3663600</ArticleId><ArticleId IdType="pubmed">23710111</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisman M (1987) Hepatic ultrastructural change and liver dysfunction in amyotrophic lateral sclerosis. Archives of neurology 44, 997.</Citation><ArticleIdList><ArticleId IdType="pubmed">3632388</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsey KM, Yoshino J, Brace CS, Abrassart D, Kobayashi Y, Marcheva B, Hong HK, Chong JL, Buhr ED, Lee C, Takahashi JS, Imai S, and Bass J (2009) Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 324, 651&#x2013;654</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2738420</ArticleId><ArticleId IdType="pubmed">19299583</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakahata Y, Sahar S, Astarita G, Kaluzova M, and Sassone-Corsi P (2009) Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324, 654&#x2013;657</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6501775</ArticleId><ArticleId IdType="pubmed">19286518</ArticleId></ArticleIdList></Reference><Reference><Citation>Masri S, Rigor P, Cervantes M, Ceglia N, Sebastian C, Xiao C, Roqueta-Rivera M, Deng C, Osborne TF, Mostoslavsky R, Baldi P, and Sassone-Corsi P (2014) Partitioning circadian transcription by SIRT6 leads to segregated control of cellular metabolism. Cell 158, 659&#x2013;672</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5472354</ArticleId><ArticleId IdType="pubmed">25083875</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittenhafer-Reed KE, Richards AL, Fan J, Smallegan MJ, Fotuhi Siahpirani A, Kemmerer ZA, Prolla TA, Roy S, Coon JJ, and Denu JM (2015) SIRT3 mediates multi-tissue coupling for metabolic fuel switching. Cell metabolism 21, 637&#x2013;646</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4393847</ArticleId><ArticleId IdType="pubmed">25863253</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar RS, Green EW, Zhao Y, van Ooijen G, Olmedo M, Qin X, Xu Y, Pan M, Valekunja UK, Feeney KA, Maywood ES, Hastings MH, Baliga NS, Merrow M, Millar AJ, Johnson CH, Kyriacou CP, O&#x2019;Neill JS, and Reddy AB (2012) Peroxiredoxins are conserved markers of circadian rhythms. Nature 485, 459&#x2013;464</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3398137</ArticleId><ArticleId IdType="pubmed">22622569</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey G, Valekunja UK, Feeney KA, Wulund L, Milev NB, Stangherlin A, Ansel-Bollepalli L, Velagapudi V, O&#x2019;Neill JS, and Reddy AB (2016) The Pentose Phosphate Pathway Regulates the Circadian Clock. Cell metabolism 24, 462&#x2013;473</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5031559</ArticleId><ArticleId IdType="pubmed">27546460</ArticleId></ArticleIdList></Reference><Reference><Citation>Pekovic-Vaughan V, Gibbs J, Yoshitane H, Yang N, Pathiranage D, Guo B, Sagami A, Taguchi K, Bechtold D, Loudon A, Yamamoto M, Chan J, van der Horst GT, Fukada Y, and Meng QJ (2014) The circadian clock regulates rhythmic activation of the NRF2/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis. Genes &amp; development 28, 548&#x2013;560</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3967045</ArticleId><ArticleId IdType="pubmed">24637114</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolanos JP (2016) Bioenergetics and redox adaptations of astrocytes to neuronal activity. Journal of neurochemistry 139 Suppl 2, 115&#x2013;125</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5018236</ArticleId><ArticleId IdType="pubmed">26968531</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter PS, and Hardingham GE (2016) Adaptive regulation of the brain&#x2019;s antioxidant defences by neurons and astrocytes. Free radical biology &amp; medicine 100, 147&#x2013;152</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5145800</ArticleId><ArticleId IdType="pubmed">27365123</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M, Harlan BA, Killoy KM, and Vargas MR (2017) Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis. Current pharmaceutical design 23, 5010&#x2013;5021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5740017</ArticleId><ArticleId IdType="pubmed">28641533</ArticleId></ArticleIdList></Reference><Reference><Citation>Brancaccio M, Patton AP, Chesham JE, Maywood ES, and Hastings MH (2017) Astrocytes Control Circadian Timekeeping in the Suprachiasmatic Nucleus via Glutamatergic Signaling. Neuron 93, 1420&#x2013;1435 e1425</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5376383</ArticleId><ArticleId IdType="pubmed">28285822</ArticleId></ArticleIdList></Reference><Reference><Citation>Tso CF, Simon T, Greenlaw AC, Puri T, Mieda M, and Herzog ED (2017) Astrocytes Regulate Daily Rhythms in the Suprachiasmatic Nucleus and Behavior. Current biology : CB 27, 1055&#x2013;1061</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5380592</ArticleId><ArticleId IdType="pubmed">28343966</ArticleId></ArticleIdList></Reference><Reference><Citation>Barca-Mayo O, Boender AJ, Armirotti A, and De Pietri Tonelli D (2020) Deletion of astrocytic BMAL1 results in metabolic imbalance and shorter lifespan in mice. Glia 68, 1131&#x2013;1147</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7496695</ArticleId><ArticleId IdType="pubmed">31833591</ArticleId></ArticleIdList></Reference><Reference><Citation>So AY, Bernal TU, Pillsbury ML, Yamamoto KR, and Feldman BJ (2009) Glucocorticoid regulation of the circadian clock modulates glucose homeostasis. Proceedings of the National Academy of Sciences of the United States of America 106, 17582&#x2013;17587</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2757402</ArticleId><ArticleId IdType="pubmed">19805059</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohawk JA, Green CB, and Takahashi JS (2012) Central and peripheral circadian clocks in mammals. Annu Rev Neurosci 35, 445&#x2013;462</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3710582</ArticleId><ArticleId IdType="pubmed">22483041</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun MC, Castillo-Ruiz A, Indic P, Jung DY, Kim JK, Brown RH Jr., Swoap SJ, and Schwartz WJ (2019) Defective daily temperature regulation in a mouse model of amyotrophic lateral sclerosis. Experimental neurology 311, 305&#x2013;312</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6263852</ArticleId><ArticleId IdType="pubmed">30031021</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, and Couratier P (1999) Nutritional status is a prognostic factor for survival in ALS patients. Neurology 53, 1059&#x2013;1063</Citation><ArticleIdList><ArticleId IdType="pubmed">10496266</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas MR, Pehar M, Cassina P, Martinez-Palma L, Thompson JA, Beckman JS, and Barbeito L (2005) Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 (Nrf2) in spinal cord astrocytes: consequences for motor neuron survival. J Biol Chem 280, 25571&#x2013;25579</Citation><ArticleIdList><ArticleId IdType="pubmed">15870071</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, Bittar R, Seilhean D, Hauw JJ, Lacomblez L, Loeffler JP, and Meininger V (2008) Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70, 1004&#x2013;1009</Citation><ArticleIdList><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat PF, Bruneteau G, Gordon PH, Dupuis L, Bonnefont-Rousselot D, Simon D, Salachas F, Corcia P, Frochot V, Lacorte JM, Jardel C, Coussieu C, Le Forestier N, Lacomblez L, Loeffler JP, and Meininger V (2010) Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11, 166&#x2013;171</Citation><ArticleIdList><ArticleId IdType="pubmed">20184518</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas MR, Johnson DA, and Johnson JA (2011) Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1(G93A) mice model. Neurobiology of disease 43, 543&#x2013;551</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3139005</ArticleId><ArticleId IdType="pubmed">21600285</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Deng J, Jaffa M, Cudkowicz ME, and Wills AM (2011) Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve 44, 20&#x2013;24</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4441750</ArticleId><ArticleId IdType="pubmed">21607987</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton KA, Cudkowicz ME, Brown MV, Alexander D, Caffrey R, Wulff JE, Bowser R, Lawson R, Jaffa M, Milburn MV, Ryals JA, and Berry JD (2012) Biochemical alterations associated with ALS. Amyotroph Lateral Scler 13, 110&#x2013;118</Citation><ArticleIdList><ArticleId IdType="pubmed">22117131</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo V, Wark PA, Jenab M, Pearce N, Brayne C, Vermeulen R, Andersen PM, Hallmans G, Kyrozis A, Vanacore N, Vahdaninia M, Grote V, Kaaks R, Mattiello A, Bueno-de-Mesquita HB, Peeters PH, Travis RC, Petersson J, Hansson O, Arriola L, Jimenez-Martin JM, Tjonneland A, Halkjaer J, Agnoli C, Sacerdote C, Bonet C, Trichopoulou A, Gavrila D, Overvad K, Weiderpass E, Palli D, Quiros JR, Tumino R, Khaw KT, Wareham N, Barricante-Gurrea A, Fedirko V, Ferrari P, Clavel-Chapelon F, Boutron-Ruault MC, Boeing H, Vigl M, Middleton L, Riboli E, and Vineis P (2013) Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology 80, 829&#x2013;838</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3598455</ArticleId><ArticleId IdType="pubmed">23390184</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas MR, Burton NC, Kutzke J, Gan L, Johnson DA, Schafer M, Werner S, and Johnson JA (2013) Absence of Nrf2 or its selective overexpression in neurons and muscle does not affect survival in ALS-linked mutant hSOD1 mouse models. PloS one 8, e56625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3572065</ArticleId><ArticleId IdType="pubmed">23418589</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Reilly EJ, Wang H, Weisskopf MG, Fitzgerald KC, Falcone G, McCullough ML, Thun M, Park Y, Kolonel LN, and Ascherio A (2013) Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 14, 205&#x2013;211</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3615420</ArticleId><ArticleId IdType="pubmed">23134505</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M, Beeson G, Beeson CC, Johnson JA, and Vargas MR (2014) Mitochondria-targeted catalase reverts the neurotoxicity of hSOD1G(9)(3)A astrocytes without extending the survival of ALS-linked mutant hSOD1 mice. PLoS One 9, e103438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4108402</ArticleId><ArticleId IdType="pubmed">25054289</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman MH, Seelen M, van Doormaal PT, de Jong SW, de Vries JH, van der Kooi AJ, de Visser M, Schelhaas HJ, van den Berg LH, and Veldink JH (2015) Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral Sclerosis. JAMA Neurol 72, 1155&#x2013;1162</Citation><ArticleIdList><ArticleId IdType="pubmed">26280944</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Arcuti S, Jesus P, Logroscino G, Copetti M, Fontana A, Nicol M, Raymondeau M, Desport JC, Preux PM, Couratier P, and French register of A. L. S. i. L. (2016) Population-Based Evidence that Survival in Amyotrophic Lateral Sclerosis is Related to Weight Loss at Diagnosis. Neurodegener Dis 16, 225&#x2013;234</Citation><ArticleIdList><ArticleId IdType="pubmed">26866503</ArticleId></ArticleIdList></Reference><Reference><Citation>Storch KF, Lipan O, Leykin I, Viswanathan N, Davis FC, Wong WH, and Weitz CJ (2002) Extensive and divergent circadian gene expression in liver and heart. Nature 417, 78&#x2013;83</Citation><ArticleIdList><ArticleId IdType="pubmed">11967526</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Lahens NF, Ballance HI, Hughes ME, and Hogenesch JB (2014) A circadian gene expression atlas in mammals: implications for biology and medicine. Proceedings of the National Academy of Sciences of the United States of America 111, 16219&#x2013;16224</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4234565</ArticleId><ArticleId IdType="pubmed">25349387</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H, Zhao X, Hatori M, Yu RT, Barish GD, Lam MT, Chong LW, DiTacchio L, Atkins AR, Glass CK, Liddle C, Auwerx J, Downes M, Panda S, and Evans RM (2012) Regulation of circadian behaviour and metabolism by REV-ERB-alpha and REV-ERB-beta. Nature 485, 123&#x2013;127</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3367514</ArticleId><ArticleId IdType="pubmed">22460952</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong L, D&#x2019;Urso A, Toiber D, Sebastian C, Henry RE, Vadysirisack DD, Guimaraes A, Marinelli B, Wikstrom JD, Nir T, Clish CB, Vaitheesvaran B, Iliopoulos O, Kurland I, Dor Y, Weissleder R, Shirihai OS, Ellisen LW, Espinosa JM, and Mostoslavsky R (2010) The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 140, 280&#x2013;293</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2821045</ArticleId><ArticleId IdType="pubmed">20141841</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao C, Kim HS, Lahusen T, Wang RH, Xu X, Gavrilova O, Jou W, Gius D, and Deng CX (2010) SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. J Biol Chem 285, 36776&#x2013;36784</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2978606</ArticleId><ArticleId IdType="pubmed">20847051</ArticleId></ArticleIdList></Reference><Reference><Citation>Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, Cheung P, Kusumoto R, Kawahara TL, Barrett JC, Chang HY, Bohr VA, Ried T, Gozani O, and Chua KF (2008) SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452, 492&#x2013;496</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2646112</ArticleId><ArticleId IdType="pubmed">18337721</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara TL, Michishita E, Adler AS, Damian M, Berber E, Lin M, McCord RA, Ongaigui KC, Boxer LD, Chang HY, and Chua KF (2009) SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136, 62&#x2013;74</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2757125</ArticleId><ArticleId IdType="pubmed">19135889</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlan BA, Killoy KM, Pehar M, Liu L, Auwerx J, and Vargas MR (2020) Evaluation of the NAD(+) biosynthetic pathway in ALS patients and effect of modulating NAD(+) levels in hSOD1-linked ALS mouse models. Exp Neurol 327, 113219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7089832</ArticleId><ArticleId IdType="pubmed">32014438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolanos JP, Almeida A, and Moncada S (2010) Glycolysis: a bioenergetic or a survival pathway? Trends in biochemical sciences 35, 145&#x2013;149</Citation><ArticleIdList><ArticleId IdType="pubmed">20006513</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundsgaard AM, Fritzen AM, and Kiens B (2018) Molecular Regulation of Fatty Acid Oxidation in Skeletal Muscle during Aerobic Exercise. Trends in endocrinology and metabolism: TEM 29, 18&#x2013;30</Citation><ArticleIdList><ArticleId IdType="pubmed">29221849</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraft AD, Resch JM, Johnson DA, and Johnson JA (2007) Activation of the Nrf2-ARE pathway in muscle and spinal cord during ALS-like pathology in mice expressing mutant SOD1. Experimental neurology 207, 107&#x2013;117</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2062571</ArticleId><ArticleId IdType="pubmed">17631292</ArticleId></ArticleIdList></Reference><Reference><Citation>Wible RS, Ramanathan C, Sutter CH, Olesen KM, Kensler TW, Liu AC, and Sutter TR (2018) NRF2 regulates core and stabilizing circadian clock loops, coupling redox and timekeeping in Mus musculus. Elife 7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5826263</ArticleId><ArticleId IdType="pubmed">29481323</ArticleId></ArticleIdList></Reference><Reference><Citation>Early JO, Menon D, Wyse CA, Cervantes-Silva MP, Zaslona Z, Carroll RG, Palsson-McDermott EM, Angiari S, Ryan DG, Corcoran SE, Timmons G, Geiger SS, Fitzpatrick DJ, O&#x2019;Connell D, Xavier RJ, Hokamp K, O&#x2019;Neill LAJ, and Curtis AM (2018) Circadian clock protein BMAL1 regulates IL-1beta in macrophages via NRF2. Proceedings of the National Academy of Sciences of the United States of America 115, E8460&#x2013;E8468</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6130388</ArticleId><ArticleId IdType="pubmed">30127006</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>